{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:30:55Z","timestamp":1795102255050,"version":"4.10.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-07932-9","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T09:36:40Z","timestamp":1737020200000},"page":"685-696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy of GnRH antagonists in the treatment of uterine fibroids: a meta-analysis"],"prefix":"10.1007","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9895-5248","authenticated-orcid":false,"given":"Mar\u00eda J\u00e9sus","family":"S\u00e1nchez Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5421-6024","authenticated-orcid":false,"given":"Cristina","family":"Huerga L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-6592","authenticated-orcid":false,"given":"Ignacio","family":"Crist\u00f3bal Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3276-231X","authenticated-orcid":false,"given":"Ignacio","family":"Crist\u00f3bal Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"7932_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1289\/ehp.5787","volume":"111","author":"GP Flake","year":"2003","unstructured":"Flake GP, Andersen J, Dixon D (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111:1037\u20131054","journal-title":"Environ Health Perspect"},{"key":"7932_CR2","first-page":"202","volume":"79","author":"C Borgfeldt","year":"2000","unstructured":"Borgfeldt C, Andolf E (2000) Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25\u201340 years. Acta Obstet Gynecol Scand 79:202\u2013207","journal-title":"Acta Obstet Gynecol Scand"},{"key":"7932_CR3","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0015-0282(03)02207-6","volume":"80","author":"SA Lippman","year":"2003","unstructured":"Lippman SA, Warner M, Samuels S et al (2003) Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril 80:1488\u20131494","journal-title":"Fertil Steril"},{"key":"7932_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/humrep\/dep396","volume":"25","author":"SK Sunkara","year":"2010","unstructured":"Sunkara SK, Khairy M, El-Toukhy T et al (2010) The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod 25:418\u2013429","journal-title":"Hum Reprod"},{"key":"7932_CR5","first-page":"431","volume":"101","author":"G Wegienka","year":"2003","unstructured":"Wegienka G, Baird DD, Hertz-Picciotto I et al (2003) Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 101:431\u2013437","journal-title":"Obstet Gynecol"},{"issue":"2204\u20138","key":"7932_CR6","first-page":"2208.e1","volume":"95","author":"MG Munro","year":"2011","unstructured":"Munro MG, Critchley HOD, Fraser IS (2011) The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 95(2204\u20138):2208.e1\u20133","journal-title":"Fertil Steril"},{"key":"7932_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/1471-0528.14383","volume":"124","author":"X Yao","year":"2017","unstructured":"Yao X, Stewart EA, Laughlin-Tommaso SK et al (2017) Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA. BJOG 124:322\u2013330","journal-title":"BJOG"},{"key":"7932_CR8","unstructured":"Hartmann KE, Fonnesbeck C, Surawicz T, et al. (2017) Management of Uterine Fibroids. Rockville (MD): Agency for Healthcare Research and Quality (US)"},{"key":"7932_CR9","first-page":"CD000547","volume":"11","author":"A Lethaby","year":"2017","unstructured":"Lethaby A, Puscasiu L, Vollenhoven B (2017) Preoperative medical therapy before surgery for uterine fibroids. Cochrane Database Syst Rev 11:CD000547","journal-title":"Cochrane Database Syst Rev"},{"key":"7932_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jmig.2022.01.015","volume":"29","author":"M Polin","year":"2022","unstructured":"Polin M, Hur H-C (2022) Radiofrequency ablation of uterine myomas and pregnancy outcomes: an updated review of the literature. J Minim Invasive Gynecol 29:709\u2013715","journal-title":"J Minim Invasive Gynecol"},{"key":"7932_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejrad.2018.10.017","volume":"109","author":"JK Yoon","year":"2018","unstructured":"Yoon JK, Han K, Kim M-D et al (2018) Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: An analysis of risk factors for reintervention. Eur J Radiol 109:83\u201387","journal-title":"Eur J Radiol"},{"key":"7932_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.fertnstert.2020.07.028","volume":"114","author":"J Donnez","year":"2020","unstructured":"Donnez J, Dolmans M-M (2020) Fibroids and medical therapy: bridging the gap from selective progesterone receptor modulators to gonadotropin-releasing hormone antagonist. Fertil Steril 114:739\u2013741","journal-title":"Fertil Steril"},{"key":"7932_CR13","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1097\/AOG.0000000000004401","volume":"137","author":"Management of Symptomatic Uterine Leiomyomas","year":"2021","unstructured":"Management of Symptomatic Uterine Leiomyomas (2021) ACOG Practice Bulletin, Number 228. Obstet Gynecol 137:e100\u2013e115","journal-title":"Obstet Gynecol"},{"key":"7932_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"7932_CR15","first-page":"65","volume":"4","author":"K Chwalisz","year":"2023","unstructured":"Chwalisz K (2023) Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix. F S Rep 4:65\u201372","journal-title":"F S Rep"},{"key":"7932_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13063-024-07923-2","volume":"25","author":"N Kawahara","year":"2024","unstructured":"Kawahara N, Kawaguchi R, Yamamoto K et al (2024) The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial. Trials 25:68","journal-title":"Trials"},{"key":"7932_CR17","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1080\/14656566.2023.2248890","volume":"24","author":"M Ciebiera","year":"2023","unstructured":"Ciebiera M, Madueke-Laveaux OS, Feduniw S et al (2023) GnRH agonists and antagonists in therapy of symptomatic uterine fibroids \u2013 current roles and future perspectives. Expert Opin Pharmacother 24:1799\u20131809","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"7932_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/GCO.0000000000000907","volume":"35","author":"O Sim-Ifere","year":"2023","unstructured":"Sim-Ifere O, Aref-Adib M, Odejinmi F (2023) Oral gonadotrophin-releasing hormone (GnRH) antagonists: the continuing search for the ideal nonsurgical therapy of uterine fibroids with a cautionary tale. Curr Opin Obstet Gynecol 35(5):460\u2013465","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"7932_CR19","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/jcm12031008","volume":"12","author":"AM Rzewuska","year":"2023","unstructured":"Rzewuska AM, \u017bybowska M, Sajkiewicz I et al (2023) Gonadotropin-releasing hormone antagonists\u2014A new hope in endometriosis treatment? J Clin Med 12(3):1008","journal-title":"J Clin Med"},{"key":"7932_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00404-022-06862-0","volume":"308","author":"L Xin","year":"2023","unstructured":"Xin L, Ma Y, Ye M et al (2023) Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis. Arch Gynecol Obstet 308:1047\u20131056","journal-title":"Arch Gynecol Obstet"},{"key":"7932_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12905-022-01596-2","volume":"22","author":"J Muhammad","year":"2022","unstructured":"Muhammad J, Yusof Y, Ahmad I et al (2022) Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis. BMC Womens Health 22:14","journal-title":"BMC Womens Health"},{"key":"7932_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2217\/whe.15.85","volume":"12","author":"SD Quinn","year":"2016","unstructured":"Quinn SD, Higham J (2016) Outcome measures for heavy menstrual bleeding. Womens Health (Lond) 12:21\u201326","journal-title":"Womens Health (Lond)"},{"key":"7932_CR23","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jogc.2022.10.012","volume":"44","author":"R Niaz","year":"2022","unstructured":"Niaz R, Saeed M, Khan H et al (2022) Efficacy and safety of oral GnRh antagonists in patients with uterine fibroids: a systematic review. J Obstet Gynaecol Can 44:1279\u20131288","journal-title":"J Obstet Gynaecol Can"},{"issue":"62","key":"7932_CR24","first-page":"674","volume":"2022","author":"RJ Rovelli","year":"2003","unstructured":"Rovelli RJ, Cieri-Hutcherson NE, Hutcherson TC (2003) Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids. J Am Pharm Assoc 2022(62):674-682.e5","journal-title":"J Am Pharm Assoc"},{"key":"7932_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.08.027","volume":"114","author":"A Al-Hendy","year":"2020","unstructured":"Al-Hendy A, Lukes AS, Poindexter A III et al (2020) Liberty: long-term extension study demonstrating one-year efficacy and safety of relugolix combination therapy in women with symptomatic uterine fibroids. Fertil Steril 114:e1","journal-title":"Fertil Steril"},{"key":"7932_CR26","first-page":"920","volume":"140","author":"A Al-Hendy","year":"2022","unstructured":"Al-Hendy A, Lukes AS, Poindexter AN 3rd et al (2022) Long-term Relugolix combination therapy for symptomatic uterine leiomyomas. Obstet Gynecol 140:920\u2013930","journal-title":"Obstet Gynecol"},{"key":"7932_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/AOG.0000000000002675","volume":"132","author":"E Surrey","year":"2018","unstructured":"Surrey E, Taylor HS, Giudice L et al (2018) Long-term outcomes of elagolix in women with endometriosis: results from two extension studies. Obstet Gynecol 132:147\u2013160","journal-title":"Obstet Gynecol"},{"key":"7932_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.fertnstert.2020.02.114","volume":"114","author":"J Donnez","year":"2020","unstructured":"Donnez J, Taylor HS, Taylor RN et al (2020) Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone\u2013antagonist: a randomized clinical trial. Fertil Steril 114:44\u201355","journal-title":"Fertil Steril"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-07932-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-07932-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-07932-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T11:46:49Z","timestamp":1742298409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-07932-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["7932"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-07932-9","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}